Athera Biotechnologies AB
PrivateLast Round
VC Round
May 21, 2019
Company Overview
Athera Biotechnologies AB operates in Healthcare & Life Sciences and is based in Stockholm. Its latest recorded funding round was a VC Round in May 2019.
Athera Biotechnologies AB is a biotechnology company that develops targeted anti-inflammatory biological candidate drugs for the prevention and treatment of cardiovascular and immunovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athera Biotechnologies AB Comparables
Compare Athera Biotechnologies AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abcentra | 84% | |
| Lisata Therapeutics | 74% | |
| Beijing Sungen Biomedical Technology Co., Ltd. | 71% |
For institutional investors. Book with your work email.
Athera Biotechnologies AB Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 21, 2019 | ||||
| VC Round | Aug 29, 2017 | ||||
| VC Round | Dec 3, 2015 |
For institutional investors. Book with your work email.
Athera Biotechnologies AB Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Industrifonden | VC Round |
| The Foundation for Baltic and East European Studies | VC Round |
| Linc AB | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2017
$7M raised from Linc AB, Industrifonden, and others.
- Dec 3, 2015
$3M round led by Industrifonden and The Foundation for Baltic and East European Studies.
For institutional investors. Book with your work email.
Athera Biotechnologies AB Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Athera Biotechnologies AB's valuation, stock price, and market status.
Is Athera Biotechnologies AB a public or private company?
Athera Biotechnologies AB is a private company.
What is the current stock price of Athera Biotechnologies AB?
Athera Biotechnologies AB is a private company, so its shares have no public market price. Caplight tracks Athera Biotechnologies AB's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Athera Biotechnologies AB worth (valuation)?
Valuation information for Athera Biotechnologies AB is not publicly available.
Can I buy Athera Biotechnologies AB stock?
Athera Biotechnologies AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Athera Biotechnologies AB's last funding round?
Athera Biotechnologies AB's most recent funding round was VC Round on May 21, 2019.
Who are the main investors in Athera Biotechnologies AB?
Key investors in Athera Biotechnologies AB include Industrifonden, The Foundation for Baltic and East European Studies.
Will Athera Biotechnologies AB IPO soon?
No public IPO plans have been announced for Athera Biotechnologies AB.
How can I track Athera Biotechnologies AB secondary market activity?
Caplight tracks bids, offers, and trades in Athera Biotechnologies AB's shares on secondary markets.